{"denoms":[{"counts":[{"groupId":"BG000","value":"79"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"80"}],"units":"Participants"}],"groups":[{"description":"Pediatric patients with relapsed or refractory B-cell ALL who were treated with single dose of tisagenlecleucel (CTL019).","id":"BG000","title":"Main Cohort: Single Dose of CTL019"},{"description":"Pediatric B-ALL patients who are very high risk at first relapse.","id":"BG001","title":"Cohort 1: Single Dose of CTL019"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"5.38","value":"12"},{"comment":"NA: Standard deviation cannot be calculated for only 1 patient","groupId":"BG001","spread":"NA","value":"4"},{"groupId":"BG002","spread":"5.42","value":"11.9"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"Years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"34"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"34"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"45"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"46"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"58"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"59"}]}],"title":"White"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"10"}]}],"title":"Asian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"11"}]}],"title":"Other"}],"paramType":"NUMBER","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"}],"populationDescription":"Full Analysis Set (FAS): The Full analysis set comprised all patients who received infusion of tisagenlecleucel."}